Bone Disorder Clinical Trials

12 recruitingLast updated: May 29, 2026

There are 12 actively recruiting bone disorder clinical trials across 7 countries. Studies span Not Applicable, Phase 4, Phase 2. Top locations include Herlev, Denmark, Herlev, Capital Region, Denmark, Beijing, Beijing Municipality, China. Updated daily from ClinicalTrials.gov.


Bone Disorder Trials at a Glance

12 actively recruiting trials for bone disorder are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Herlev, Herlev, and Beijing. Lead sponsors running bone disorder studies include Ditte Hansen, Grigore T. Popa University of Medicine and Pharmacy, and Capital Medical University.

Browse bone disorder trials by phase

Treatments under study

About Bone Disorder Clinical Trials

Looking for clinical trials for Bone Disorder? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Bone Disorder trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Bone Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Not Applicable

Phosphate Assessment in Chronic Kidney Disease Patients Study

Chronic Kidney Disease-Mineral and Bone DisorderChronic Kidney Disease (Stage 3-4)
University of Texas Southwestern Medical Center60 enrolled1 locationNCT07368946
Recruiting
Not Applicable

The Effect of REgulation of PArathyroId hoRmone in Patients With Chronic Kidney Disease to Investigate the Change in Bone Mineral Density

Chronic Kidney Disease-Mineral and Bone Disorder
Herlev Hospital70 enrolled1 locationNCT07171216
Recruiting

The CPH-MBD Cohort Dietary Substudy - Comparison of Methods for Dietary Registrations

CKDRenal Insufficiency, ChronicCKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder+1 more
University of Copenhagen50 enrolled2 locationsNCT07312981
Recruiting

Assessment of Mineral and Bone Disorders in Kidney Transplant Recipients

OsteoporosisCKD-MBD - Chronic Kidney Disease Mineral and Bone DisorderHemodyalysis+1 more
Grigore T. Popa University of Medicine and Pharmacy180 enrolled1 locationNCT07141043
Recruiting
Phase 2

Activated Charcoal Use in Chronic Kidney Disease Patients

End Stage Renal Disease (ESRD)CKD 5D, HemodialysisCKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder
Mansoura University40 enrolled1 locationNCT06906874
Recruiting

Characterization of Familial Myopathy and Paget Disease of Bone

Muscle DisorderBone Disorder
University of California, Irvine25 enrolled1 locationNCT01166854
Recruiting

Clinico-biological Collection of Bone, Calcium and Growth Plate Pathologies

Bone Disorder
University Hospital, Toulouse350 enrolled1 locationNCT06444503
Recruiting
Phase 4

Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease

Chronic Kidney DiseasesCardiac DiseaseChronic Kidney Disease-Mineral and Bone Disorder+1 more
Ditte Hansen48 enrolled4 locationsNCT04522622
Recruiting

Chinese CKD-MBD Prevalence Survey (CRISS-MBD)

Chronic Kidney DiseasesChronic Kidney Disease-Mineral and Bone Disorder
Limeng Chen10,254 enrolled40 locationsNCT04714918
Recruiting
Phase 4

Neutrophil Gelatinase-associated Lipocalin VS Vascular Calcification in Maintenance Hemodialysis Patients

Chronic Kidney Disease-Mineral and Bone Disorder
Xiaoyan Jia80 enrolled1 locationNCT05720273
Recruiting

GROWing Up With Rare GENEtic Syndromes

Cornelia De Lange SyndromeCongenital Adrenal HyperplasiaPrader-Willi Syndrome+30 more
dr. Laura C. G. de Graaff-Herder600 enrolled1 locationNCT04463316
Recruiting

Integrated Diagnosis and Treatment of CKD on Outcomes

HypertensionChronic Kidney DiseasesHyperlipidemias+4 more
Capital Medical University1,000 enrolled1 locationNCT05242055